Vishnevskaia E E, Okeanova N I, Shelkovich S E, Matylevich O P
N.N. Alexandrov Research Institute of Oncology and Medical Radiology, Minsk, Belarus.
Vopr Onkol. 2001;47(3):355-9.
The efficacy of stage II cervical cancer (CC) treatment was evaluated in two groups: squamous cell carcinoma--151, cervical adenocarcinoma (CAC)--49. All the patients received combined treatment (preoperative large-fraction brachytherapy + surgery + postoperative radiation). A comparison of the results highlighted the role of morphological pattern of tumor as a factor of cure. Five-year survival rates for CAC stage II patients were lower by 12.4% while the incidence of distant lymphogenous metastases and those to organs, responsible for failed therapy, was 2.7 times as high.